11.07.2013 - QVT Financial, the third-largest shareholder in obesity drugmaker Vivus, intends to vote for the full slate of nine directors proposed by dissident investor First Manhattan, a...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)